FDA Clears Leica Microsystems AR Visualization Solution GLOW800

Leica Microsystems have received 510(k) clearance from the US Food and Drug Administration (FDA) to market its augmented reality (AR) GLOW800 surgical fluorescence for vascular neurosurgery. In combination with Indocyanine Green (IGG), GLOW800 provides surgeons with the means to observe cerebral anatomy in natural colour, augmented by real-time vascular flow in a single image, with full depth perception. This AR solution allows surgeons with a complete view of anatomy and physiology to support crucial decisions and actions during vascular neurosurgery.

“For the past decade Leica Microsystems has been pioneering new fluorescence imaging technologies in partnership with surgeons to advance surgical practices,” Explains Markus Lusser, President of Leica Microsystems. “GLOW800 and future modalities based on the GLOW AR platform will allow surgeons to perform life-changing neurosurgical interventions with the confidence that they have the best possible visual information right in the field of view.”
First revealed back in October of last year, the GLOW800 AR fluorescence is the first of many imaging modalities that will be based on the GLOW AR platform from Leica Microsystems. The GLOW AR modalities can be fully integrated into the ARveo digital AR microscope which launched earlier this year. From here and following the FDA 510(k) clearance of the GLOW800, ARveo customers in the United States will be able to experience the full advantages of AR visualization in the operating room which will dynamically change up how surgeons carry out operations.

“Leica Microsystems is a company that works closely with neurosurgeons to bring new technologies to market that really respond to our needs,” Adds Cleopatra Charalampaki, Professor of Neurosurgery, Cologne Medical Center, Germany. “GLOW800 AR is an exciting new approach which provides a totally new view during vascular neurosurgery. I have excellent spatial orientation and I am impressed with the crisp delineation of vessels. I believe GLOW800 AR fluorescence will have a significant impact on surgical outcomes in the future.”
VRFocus will be sure to continue to bring you all the latest on all things virtual reality (VR) and AR in the future, along with all the developments on Leica Microsystems, so stay tuned for more.

Source: FDA Clears Leica Microsystems AR Visualization Solution GLOW800